Journal of Clinical Endocrinology & Metabolism, Vol 67, 474-479, Copyright © 1988 by Endocrine Society

ARTICLES

Premature thelarche and central precocious puberty: the relationship between clinical presentation and the gonadotropin response to luteinizing hormone-releasing hormone

OH Pescovitz, KD Hench, KM Barnes, DL Loriaux and GB Cutler Jr
Developmental Endocrinology Branch, National Institute of Child Health and Human Development, Bethesda, MD 20892.

Premature thelarche is a benign condition that affects young girls. In contrast, central precocious puberty is considered a more serious disorder that causes progressive secondary sexual development, accelerated growth and skeletal maturation, early epiphyseal fusion, and short adult stature. Differentiation between these 2 conditions is important, but may be difficult on clinical grounds, since patients with both disorders may present initially as isolated breast development. To examine the potential usefulness of gonadotropin measurements in distinguishing early central precocious puberty from premature thelarche, we measured basal and LHRH-stimulated plasma gonadotropin levels in 58 girls with idiopathic premature breast development. The girls were divided into six clinically distinct groups, based on the severity of clinical presentation, ranging from isolated breast development (group A) to complete secondary sexual development and accelerated growth and skeletal maturation (group F). The mean basal plasma LH levels and the peak LH response to LHRH stimulation were significantly less in girls with isolated thelarche (group A) than in girls with complete sexual development (group F). The mean basal plasma FSH levels did not differ between these groups, but the peak FSH response to LHRH was greater in girls with isolated thelarche than in girls with complete sexual development. Thus, girls with isolated premature thelarche had a FSH-predominant response to LHRH [mean ratio of peak LH to peak FSH, 0.29 +/- 0.10 (+/- SD)], while girls with complete sexual development had a LH-predominant response (peak LH/FSH, 4.16 +/- 1.80). All girls with isolated thelarche had peak LH/FSH ratios less than 1, and all girls with complete sexual development had a ratio greater than 1. Girls with early or intermediate manifestations of central precocious puberty, who had features of puberty in addition to breast development but lacked all of the features of group F, comprised groups B-E. These girls also had intermediate peak LH/FSH ratios, ranging from 0.29 +/- 0.10 (group B) to 3.35 +/- 2.66 (group E). We conclude that girls with early central precocious puberty frequently have LH and FSH responses to LHRH that are indistinguishable from the FSH-predominant responses of girls with isolated thelarche. These data are consistent with the hypothesis that premature thelarche and central precocious puberty may represent different positions along a continuum of hypothalamic LHRH neuron activation.

This article has been cited by other articles:

				M. G. Teles, S. D.C. Bianco, V. N. Brito, E. B. Trarbach, W. Kuohung, S. Xu, S. B. Seminara, B. B. Mendonca, U. B. Kaiser, and A. C. Latronico A GPR54-Activating Mutation in a Patient with Central Precocious Puberty N. Engl. J. Med., February 14, 2008; 358(7): 709 - 715. [Abstract] [Full Text] [PDF]

				E. A. M. R. Resende, B. H. J. Lara, J. D. Reis, B. P. Ferreira, G. A. Pereira, and M. F. Borges Assessment of Basal and Gonadotropin-Releasing Hormone-Stimulated Gonadotropins by Immunochemiluminometric and Immunofluorometric Assays in Normal Children J. Clin. Endocrinol. Metab., April 1, 2007; 92(4): 1424 - 1429. [Abstract] [Full Text] [PDF]

				L. de Vries, G. Horev, M. Schwartz, and M. Phillip Ultrasonographic and clinical parameters for early differentiation between precocious puberty and premature thelarche. Eur. J. Endocrinol., June 1, 2006; 154(6): 891 - 898. [Abstract] [Full Text] [PDF]

				H. J. Hirsch, D. Gillis, D. Strich, B. Chertin, A. Farkas, T. Lindenberg, H. Gelber, and I. M. Spitz The Histrelin Implant: A Novel Treatment for Central Precocious Puberty Pediatrics, December 1, 2005; 116(6): e798 - e802. [Abstract] [Full Text] [PDF]

				K. Lin-Su, M. G. Vogiatzi, I. Marshall, M. D. Harbison, M. C. Macapagal, B. Betensky, S. Tansil, and M. I. New Treatment with Growth Hormone and Luteinizing Hormone Releasing Hormone Analog Improves Final Adult Height in Children with Congenital Adrenal Hyperplasia J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3318 - 3325. [Abstract] [Full Text] [PDF]

				P. Kaplowitz Clinical Characteristics of 104 Children Referred for Evaluation of Precocious Puberty J. Clin. Endocrinol. Metab., August 1, 2004; 89(8): 3644 - 3650. [Abstract] [Full Text] [PDF]

				H. Jung, E. N. Probst, B. P. Hauffa, C.-J. Partsch, and O. Dammann Association of Morphological Characteristics with Precocious Puberty and/or Gelastic Seizures in Hypothalamic Hamartoma J. Clin. Endocrinol. Metab., October 1, 2003; 88(10): 4590 - 4595. [Abstract] [Full Text] [PDF]

				M. R. Palmert and P. A. Boepple Variation in the Timing of Puberty: Clinical Spectrum and Genetic Investigation J. Clin. Endocrinol. Metab., June 1, 2001; 86(6): 2364 - 2368. [Abstract] [Full Text] [PDF]

				Long-Term Outcome after Depot Gonadotropin-Releasing Hormone Agonist Treatment of Central Precocious Puberty: Final Height, Body Proportions, Body Composition, Bone Mineral Density, and Reproductive Function J. Clin. Endocrinol. Metab., December 1, 1999; 84(12): 4583 - 4590. [Abstract] [Full Text]

				V. N. Brito, M. C. Batista, M. F. Borges, A. C. Latronico, M. B. F. Kohek, A. C. P. Thirone, B. H. Jorge, I. J. P. Arnhold, and B. B. Mendonca Diagnostic Value of Fluorometric Assays in the Evaluation of Precocious Puberty J. Clin. Endocrinol. Metab., October 1, 1999; 84(10): 3539 - 3544. [Abstract] [Full Text] [PDF]

				K. Oerter Klein Editorial: Precocious Puberty: Who Has It? Who Should Be Treated? J. Clin. Endocrinol. Metab., February 1, 1999; 84(2): 411 - 414. [Full Text]

				M. R. Palmert, H. V. Malin, and P. A. Boepple Unsustained or Slowly Progressive Puberty in Young Girls: Initial Presentation and Long-Term Follow-Up of 20 Untreated Patients J. Clin. Endocrinol. Metab., February 1, 1999; 84(2): 415 - 423. [Abstract] [Full Text]